- National Resilience announced long-term debt financing of up to $825 million from Oak Hill Advisors to support its CDMO growth and manufacturing expansion.
- The investment will accelerate operations in Cincinnati and Toronto and strengthen the company’s financial position.
National Resilience has announced a long-term debt financing agreement of up to $825 million from Oak Hill Advisors (OHA) to strengthen its balance sheet and support future growth. The capital will enable the company to advance its contract manufacturing (CDMO) strategy and invest in its core facilities in Cincinnati and Toronto.
The financing, which includes a $600 million first lien commitment from OHA, will be issued in multiple tranches. The first $525 million is expected to be funded in the fourth quarter, with the remainder to follow in subsequent years. Jefferies LLC acted as financial advisor, and Kirkland & Ellis LLP served as legal counsel for the transaction.
Resilience’s focus remains on expanding its CDMO operations, particularly in sterile drug manufacturing and aseptic production. The company is developing its Cincinnati site into one of the largest and most advanced sterile injectable and device assembly facilities in North America.
“This financing is a pivotal step forward for our enterprise and positions us well to advance our ongoing transformation efforts backed by favourable industry tailwinds in the CDMO sector.”
William S. Marth, President and Chief Executive Officer of Resilience
In addition to securing the new financing, Resilience has resolved lease obligations related to underutilised sites to further optimise its balance sheet.
